18426 Federal Register / Vol. 80, No. 65 / Monday, April 6, 2015 / Notices 

their child and community. Policies that 

do not do this should be strengthened. 

4.1.1 Increased efforts should be 

made to educate the public and state 

legislatures on the safety and value of 

vaccines, the importance of 

recommended vaccinations and the 

ACIP schedule, and the risks posed by 

low or under-vaccination in 

communities and schools. 

4.2 NVAC recommends information 

on vaccination rates, vaccination 

exemptions, and other preventative 

health measures (e.g., whether a school 

has a school nurse, etc.) for an 

educational institution be made 

available to parents. 

4.2.1 Encourage educational 

institutions and childcare facilities to 

report vaccination rates publicly (e.g., 

via a school health grade or report). 

4.3 NVAC recommends ‘‘on-time 

vaccination’’ should be included as a 

Quality Measure for all health plans, 

public and private, as a first line 

indicator of vaccine confidence. NVAC 

acknowledges that other issues, such as 

access, can also effect on time 

vaccination. 

Final Recommendation 

5.1 The NVAC recommends that the 

National Vaccine Program Office 

(NVPO) should work with federal and 

non-federal partners to develop an 

implementation plan to address vaccine 

confidence, including metrics, and 

report back to NVAC on progress, 

annually. 

II. Request for Comment 

NVPO, on behalf of the NVAC 

Vaccine Confidence Working Group, 

requests input on the draft report and 

draft recommendations. Please limit 

your comments to three (3) pages. 

III. Potential Responders 

HHS invites input from a broad range 

of stakeholders including individuals 

and organizations that have interests in 

immunization efforts and the role of 

HHS in advancing those efforts. 

Examples of potential responders 

include, but are not limited to, the 

following: 

—General public; 

—advocacy groups, non-profit 

organizations, and public interest 

organizations; 

—academics, professional societies, and 

healthcare organizations; 

—public health officials and 

immunization program managers; 

—pediatric provider groups including 

all physician and non-physician 

providers that administer healthcare 

services to children, including 

pharmacists; and 

—representatives from the private 

sector, including those from health 

insurance organizations. 

When responding, please self-identify 

with any of the above or other categories 

(include all that apply) and your name. 

Anonymous submissions will not be 

considered. Written submissions should 

not exceed three to five (3–5) pages. 

Please do not send proprietary, 

commercial, financial, business, 

confidential, trade secret, or personal 

information. 

Dated: March 31, 2015. 

Bruce Gellin, 

Deputy Assistant Secretary for Health, 

Director, National Vaccine Program Office, 

Executive Secretary, National Vaccine 

Advisory Committee. 

[FR Doc. 2015–07778 Filed 4–3–15; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

will publish periodic summaries of 

proposed projects. To request more 

information on the proposed projects or 

to obtain a copy of the information 

collection plans, call the SAMHSA 

Reports Clearance Officer on (240) 276– 

1243. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: Notification of Intent 

To Use Schedule III, IV, or V Opioid 

Drugs for the Maintenance and 

Detoxification Treatment of Opiate 

Addiction Under 21 U.S.C. 823(g)(2) 

(OMB No. 0930–0234)—Extension 

The Drug Addiction Treatment Act of 

2000 (‘‘DATA,’’ Pub. L. 106–310) 

amended the Controlled Substances Act 

(21 U.S.C. 823(g)(2)) to permit 

practitioners (physicians) to seek and 

obtain waivers to prescribe certain 

approved narcotic treatment drugs for 

the treatment of opiate addiction. The 

legislation sets eligibility requirements 

and certification requirements as well as 

an interagency notification review 

process for physicians who seek 

waivers. The legislation was amended 

in 2005 to eliminate the patient limit for 

physicians in group practices, and in 

2006, to permit certain physicians to 

treat up to 100 patients. 

To implement these provisions, 

SAMHSA developed a notification form 

(SMA–167) that facilitates the 

submission and review of notifications. 

The form provides the information 

necessary to determine whether 

practitioners (i.e., independent 

physicians) meet the qualifications for 

waivers set forth under the new law. 

Use of this form will enable physicians 

to know they have provided all 

information needed to determine 

whether practitioners are eligible for a 

waiver. 

However, there is no prohibition on 

use of other means to provide requisite 

information. The Secretary will convey 

notification information and 

determinations to the Drug Enforcement 

Administration (DEA), which will 

assign an identification number to 

qualifying practitioners; this number 

will be included in the practitioner’s 

registration under 21 U.S.C. 823(f). 

Practitioners may use the form for 

three types of notification: (a) New, (b) 

immediate, and (c) to notify of their 

intent to treat up to 100 patients. Under 

‘‘new’’ notifications, practitioners may 

make their initial waiver requests to 

SAMHSA. ‘‘Immediate’’ notifications 

inform SAMHSA and the Attorney 

General of a practitioner’s intent to 

prescribe immediately to facilitate the 

treatment of an individual (one) patient 

under 21 U.S.C. 823(g)(2)(E)(ii). Finally, 

the form may be used by physicians 

with waivers to certify their need and 

intent to treat up to 100 patients. 

The form collects data on the 

following items: Practitioner name; state 

medical license number and DEA 

registration number; address of primary 

location, telephone and fax numbers; 

email address; name and address of 


tkelley on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 65 / Monday, April 6, 2015 / Notices 18427 

group practice; group practice employer 

identification number; names and DEA 

registration numbers of group 

practitioners; purpose of notification 

new, immediate, or renewal; 

certification of qualifying criteria for 

treatment and management of opiate 

dependent patients; certification of 

capacity to refer patients for appropriate 

counseling and other appropriate 

ancillary services; certification of 

maximum patient load, certification to 

use only those drug products that meet 

the criteria in the law. The form also 

notifies practitioners of Privacy Act 

considerations, and permits 

practitioners to expressly consent to 

disclose limited information to the 

SAMHSA Buprenorphine Physician 

Locator. 

Since July 2002, SAMHSA has 

received over 25,000 notifications and 

has certified almost 27,000 physicians. 

Fifty-none percent of the notifications 

were submitted by mail or by facsimile, 

with approximately forty-one percent 

submitted through the Web based online 

system. Approximately 60 percent of the 

certified physicians have consented to 

disclosure on the SAMHSA 

Buprenorphine Physician Locator. 

Respondents may submit the form 

electronically, through a dedicated Web 

page that SAMHSA will establish for the 

purpose, as well as via U.S. mail. 

There are no changes to the forms and 

burden hours. 

The following table summarizes the 

estimated annual burden for the use of 

this form. 

Purpose of submission Number of 

respondents 

Responses 

per 

respondent 

Burden per 

response 

(hour) 

Total burden 

(hours) 

Initial Application for Waiver ............................................................................ 1,500 1 .083 125 

Notification to Prescribe Immediately .............................................................. 50 1 .083 4 

Notice to Treat up to 100 patients ................................................................... 500 1 .040 20 

Total .......................................................................................................... 2,050 ........................ ........................ 149 

Send comments to Summer King, 

SAMHSA Reports Clearance Officer, 

Room 2–1057, One Choke Cherry Road, 

Rockville, MD 20857 or email her a 

copy at summer.king@samhsa.hhs.gov. 

Written comments should be received 

by June 5, 2015. 

Summer King, 

Statistician. 

[FR Doc. 2015–07727 Filed 4–3–15; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number CDC–2015–0008; NIOSH– 

282] 

International Labour Office (ILO) 

Reference Radiographs 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for information and 

comment. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease and 

Prevention is collaborating with the 

Labour Inspection, Labour 

Administration and Occupational Safety 

and Health Branch of the International 

Labour Office (ILO) in developing a set 

of digital reference radiographs for the 

ILO International Classification of 

Radiographs of Pneumoconiosis (ILO 

Classification). The current ILO 

Classification depends on 22 standard 

reference radiographs that are used to 

formally identify and characterize 

pneumoconiosis and related pulmonary 

abnormalities arising from occupational 

exposure. The original standards were 

based on film radiography, but the 

advent of digital radiography has led to 

the need for reference standards based 

on digitally-acquired images. NIOSH is 

assisting the ILO in the process of 

identifying such digital images. 

For this purpose, NIOSH is requesting 

trained users of the ILO Classification 

(e.g., NIOSH B-Readers [1] and other 

such experts) to submit comments 

regarding any of the current standard 

reference images that are felt to be 

deficient and for which improvements 

could be made. The current structure 

and format of the ILO Classification is 

to remain unchanged at the present 

time. NIOSH is not soliciting comments 

on the ILO Classification itself. 

Comments received on the ILO 

Classification will be considered 

irrelevant to the purpose of this docket. 

DATES: Electronic or written comments 

must be received by June 5, 2015. 

ADDRESSES: You may submit comments, 

identified by CDC–2015–0008 and 

docket number NIOSH–282, by any of 

the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: National Institute for 

Occupational Safety and Health, NIOSH 

Docket Office, 1090 Tusculum Avenue, 

MS C–34, Cincinnati, OH 45226–1998. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

(CDC–2015–0008; NIOSH–282). All 

relevant comments received will be 

posted without change to 

www.regulations.gov, including any 

personal information provided. All 

electronic comments should be 

formatted as Microsoft Word. For access 

to the docket to read background 

documents or comments received, go to 

www.regulations.gov. All information 

received in response to this notice will 

also be available for public examination 

and copying at the NIOSH Docket 

Office, 1150 Tusculum Avenue, Room 

155, Cincinnati, OH 45226. 

FOR FURTHER INFORMATION CONTACT: 

Michael Attfield, 1095 Willowdale 

Road, Morgantown, WV 26505–2888, 

telephone (304) 285–5737 (this is not a 

toll free number). 

SUPPLEMENTARY INFORMATION: 

Table of Contents 

• Background 

• Information Needs 

• References 

Background: Chest radiographs (XRays) provide critical medical 

information for the assessment of the 

pneumoconioses and related disorders 

in individuals, for example, those 

caused by inhaling coal, silica, and 

asbestos dusts [2]. Prior to 1950, the 

information evident on a radiograph 

could only be interpreted qualitatively. 

However in 1950, the International 

Labour Office (ILO) established a more 

quantitative system whereby the various 

parenchymal and pleural changes could 

be formally recognized and categorized. 


tkelley on DSK4VPTVN1PROD with NOTICES